| Literature DB >> 18978278 |
S H M Verdegaal1, W E Corver, P C W Hogendoorn, A H M Taminiau.
Abstract
Surgery is considered to be the most effective treatment for cartilaginous tumours. In recent years, a trend has emerged for patients with low-grade tumours to be treated less invasively using curettage followed by various forms of adjuvant therapy. We investigated the potential for phenol to be used as an adjuvant. Using a human chondrosarcoma-derived cartilage-producing cell line OUMS-27 as an in vitro model we studied the cytotoxic effect of phenol and ethanol. Since ethanol is the standard substance used to rinse phenol out of a bone cavity, we included an assessment of ethanol to see whether this was an important secondary factor with respect to cell death. The latter was assessed by flow cytometry. A cytotoxic effect was found for concentrations of phenol of 1.5% and of ethanol of 42.5%. These results may provide a clinical rationale for the use of both phenol and ethanol as adjuvant therapy after intralesional curettage in low-grade central chondrosarcoma and justify further investigation.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18978278 DOI: 10.1302/0301-620X.90B11.21029
Source DB: PubMed Journal: J Bone Joint Surg Br ISSN: 0301-620X